The preoccupation with journal IF is generated by the scientists comprising the review committees responsible for hiring, promotion, or funding decisions.

There have been two distinct responses to the replication crisis – by instituting measures like registered reports and by making data openly available. But another group continues to remain in denial.

The goal is to customize treatments for cancer and other diseases to a patient's own biology. But something as simple as failing to take care of tissue samples en route to the lab can derail that.

Lucy Patterson reports back from Science Hack Day Berlin.

Initiatives are in place to keep early-career investigators in the biomedical system, but more support is needed.

A 30 page paper panning the Commission’s copyright plans on press publishers written by JRC never saw the light of the day.

The focus on child care may conceal a bigger barrier to female participation in the labor force: tending to the growing ranks of aging family members.

How do we create a social structure to foster empowerment?

Counting the number of women and men is considered to be rather unproblematic. But how do you measure diversity?

The role of Canada's new Chief Science Advisor in evidence-based decision-making.

Blockchain could lend security measures to the scientific process, but the approach has its own risks.

Jim Kozubek on the potential problems of profiteering in biotech.

Roxane Feller, AnimalhealthEurope Secretary-General provides a fascinating insight into the global challenge of antibiotic resistance.

In 2017, scientists, regulators, and publishers clashed in a series of lawsuits, boycotts, mass resignations, and more.

Some experts say the US decision to repeal net neutrality rules could open the floodgates to a multi-speed internet in Europe.

Amidst the push from universities and funding agencies for increased interdisciplinary research, interdisciplinarity has also been the subject of a number of critiques in recent years.

Academic cultural critique is best served in blog form and there are a slew of academic blogs waiting to dish. We’ve picked 9 of the best academic blogs.

My bullying supervisor damaged my mental health. But when I decided to stand up to them, I received no support from my university.

As a new president takes office, scientists in the country and beyond should urge the administration to make science a priority, says Dexter Tagwireyi.

Even lobbyists admit that’s the plan behind the extra EU copyright for news.

Its government is virtual, borderless, blockchained, and secure. Has this tiny post-Soviet nation found the way of the future?

Climatologist Katherine Hayhoe says that scientists have no option but to fight against the politicisation of science.

Moves to create a multi-speed Internet could push science into the slow lane.

Prominent climate researcher Ken Caldeira says the House tax bill would prevent many graduate students from pursuing advanced degrees and carrying out critical research.

Terence Karran is fighting for a European agreement to enshrine researchers’ rights: a ‘Magna Carta’ for science.

What can a crowdsourced survey of sexual harassment in academe tell us about the problem?

Opinion pieces that “represent the viewpoint of an individual” and offer hypotheses without testing them are the opposite of science.

The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.

Les Hatton and Gregory Warr give their two-pronged solution to the problems of peer review

A surprising amount of publicly funded research data stays private. How could that change?